Pharmacy

Alpha Index R

Home » Alpha Index » Alpha Index R

List of Drugs:

A  B  C  D  E  F  G  H  I  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Z  #

Products R:

RABICIP Aciphex

RALISTA Evista

RANITIDINE Generic Zantac

Ranolaz Ranexa

RAPACAN Rapamune

Rapamune Generic Sirolimus

Rasalect Azilect

Rasilez Tekturna

RASTINON Orinase

RAZEL Crestor

Rcifax Xifaxan

R CIN Rifadin

Rebose Prebose

REBOXXIN Edronax

RECLIDE Vivazide

Refzil O Cefzil

REGLAN Clopra

Reglan (Metoclopramide)

Relestat Eye Drops Elestat

Remeron (Mirtazapine)

Reminyl Razadyne

Remoxil Amoxil

RENEDIL Plendil

Renitec Vasotec

RENODAPT Cellcept

Requip Generic Ropinirole

Restasis Eye Drops Generic Cyclosporine

Retin A Avita

Retin-A (Tretinoin)

RETINO A Avita

Retino A Cream Retin A

Retrovir (Zidovudine)

Revia (Naltrexone)

REVIBRA Celebrex

REVOCON Nitoman

REZULT Avandia

Rheumacin Indocin

Rheumacin SR Indocin

Rhinocort AqNasal Spray Rhinocort Aqua

RIBAVIN ribavirin

Rifadin (Rifampin)

RIMOSLIM Acomplia

Riomont Acomplia

Risofos Actonel

Risperdal Generic Risperidone

Risperdal (Risperidone)

Ritomune Norvir

Rivamer Exelon

Rizact Maxalt

Robinax Robaxin

ROCALTROL Generic Calcitriol

Rocephin IM Ceftriaxone Sodium Injection

Roliten Detrol

ROPARK Requip

Rosicon G Avandaryl

Rosiglitazone Avandia

Rosuvatin Crestor

ROTAHALER Rotacap Dispenser

ROZUCOR Crestor

Rulide (Roxithromycin)

Previous  Next

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.